Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Specialized Commissioning Clinical Commissioning Policies Work Programme updated in England

On July 01, 2021, NHS England published an update of the Specialized Services Policy Pipeline (covering March 21, 2021 - June 21, 2021).

Two types of Work Programmes exist:

  • Clinical commissioning policy work program;
  • Specialized commissioning service specification work program;

Updates were only made in the clinical commissioning policy work program. Three new policies were added to the work program; however, all related to pharmaceuticals only.

One new policy related to MedTech was published on proton beam therapy for breast cancer (all ages). It was concluded that there is not enough evidence, and proton beam therapy is not recommended to be available as a treatment option for breast cancer.

See the full details in English here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).